Aleks Engel

 

Board Member

Ph.D. Biochemical Engineering (M.I.T.)

M.Sc. Chemical Engineering (M.I.T.)

Linkedin


Global M&A & Licensing

 

Go-To Market Strategy

Biography

Aleks joined the Bactolife™ Board of Directors in May 2021

Aleks Engel is a partner with Novo Holdings based in Boston. He joined Novo Holdings in 2014 in Copenhagen and has since 2018 led anti-infective investment activities (the REPAIR Impact Fund and a board position in the AMR Action Fund).  Aleks previously worked in business development for Baxter International and Pfizer in the United States and China and prior to that was a consultant with McKinsey and Company.  He obtained his Ph.D. in biochemical engineering and M.S. in chemical engineering from M.I.T.  Aleks grew up on a farm in Denmark.